Skip to main content

Table 1 (abstract P114). See text for description

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

Parameters

Uveitis, yes n=32

Uveitis, no n=143

Р

Onset age, years

3.9 (2.1; 6.2)

5.5 (2.5; 10.5)

0.033

ANA positivity, n (%)

15/26 (57.7)

26/72 (36.1)

0.056

Ongoing methotrexate, n (%)

26 (81.3)

103 (72.0)

0.284

Time before 1st biologics, months

2.9 (1.5; 5.3)

2.2 (1.0; 5.2)

0.343

Remission duration, months

6.5 (2.4; 6.9)

13.1 (6.5; 28.0)

0.078

First significant flare, n (%)

14 (43.8)

24/142 (16.9)

0.0009

Time before first significant flare, months

33.0 (16.7; 61.5)

48.6 (26.4; 65.7)

0.023

Switching of the first biologic, n (%)

7 (21.9)

18/142 (12.7)

0.180

Time before switching of the first biologics, months

49.0 (24.5; 62.1)

52.3 (35.0; 66.2)

0.186